Back to results
US 11,305,119 B2Granted
System and method to modulate phrenic nerve to prevent sleep apnea
AssigneeZoll Respicardia, Inc.
InventorsMark Gelfand, Howard R. Levin, Andrew Halpert
Life of this patent
Estimating the term…
Abstract
An implantable medical device for treating breathing disorders such as central sleep apnea wherein stimulation is provided to the phrenic never through a transvenous lead system with the stimulation beginning after inspiration to extend the duration of a breath and to hold the diaphragm in a contracted condition.
Claims10
A method of preventing an apneic episode, the method comprising:
- implanting a stimulation electrode in a vein of a patient proximate a phrenic nerve;
- monitoring the breathing of the patient including a breathing rate and at least an inspiration phase and an expiration phase of an intrinsic breath;
- obtaining breathing rate data of the patient with a monitoring device;
- determining a breathing rate intervention setpoint;
- determining when the breathing rate exceeds the breathing rate intervention setpoint;
- and
- providing at least one electric pulse to the stimulation electrode for a stimulation period that starts during the inspiration phase to capture the phrenic nerve which affects lung function of the patient such that air is trapped in the lung of the patient, wherein stimulation is continued for a period of time within the stimulation period after airflow has been substantially halted such that lung volume remains substantially constant during the stimulation period which results in a duration of a stimulated breath being extended to maintain carbon dioxide levels within the blood of the patient and maintain a neural respiratory drive to prevent the apneic episode.
4 more elements
Dependencies are inferred from the claim text.